17 August, 2018
The report of the Rhinology Future Debates 2017 is now available online.Novel developments in #Rhinology are presented to a panel of experts and patients, and the strengths, weaknesses and potential positioning in the care pathways are debatedhttps://onlinelibrary.wiley.com/doi/abs/10.1111/coa.13184/
The Rhinology Future Debate took place in Brussels in December 2017 as a discussion forum in the respiratory field. The panel concluded that patient-friendly treatment approaches are important.
The KOS treatment was concluded to be a patient-friendly technique as a non-surgical option of idiopathic rhinitis and chronic nose congestion.
If you want to read our press releases, there are available in the Investor Relations section or by clicking the link below.
For questions about Chordate's share price or other investment-related topics, please see if the answer is here.
For questions about the medical effects of the K.O.S treatment, please see if the answer is here.
To get in touch with Chordate regarding other questions, use the adjecent form. We do our best to respond as quickly as possible.